Channel Therapeutics
Why Robinhood?
You can watch CHRO and buy or sell other stocks, ETFs, and their options commission-free!About CHRO
Pelthos Therapeutics, Inc. engages in the provision of therapeutic products. It produces products under its proprietary nitic oxide-based technology platform Nitricil.
CHRO Key Statistics
Stock Snapshot
As of today, Channel Therapeutics(CHRO) shares are valued at $13.50. The company's market cap stands at 50.2M, with a P/E ratio of -0.64.
On 2026-10-26, Channel Therapeutics(CHRO) stock opened at —, reached a high of —, and a low of —.
Channel Therapeutics(CHRO) shares are trading with a volume of 0, against a daily average of 68.27K.
In the last year, Channel Therapeutics(CHRO) shares hit a 52-week high of $37.50 and a 52-week low of $16.94.
In the last year, Channel Therapeutics(CHRO) shares hit a 52-week high of $37.50 and a 52-week low of $16.94.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.